Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Triphase Accelerator and Celgene enter new collaboration

Dec. 23, 2016

BioInvent and Pfizer sign cancer immunotherapy research collaboration and license agreement

Dec. 23, 2016

PsiOxus Therapeutics and BMS sign exclusive worldwide license agreement for NG-348

Dec. 22, 2016

Phase I data for novel anti-CD22 CAR therapy in pediatric and young adult patients with ALL

Dec. 22, 2016

MaxCyte and Washington University form immuno-oncology collaboration

Dec. 22, 2016

Janssen applies for approval of daratumumab in Japan

Dec. 21, 2016

JCAR-017 obtains FDA breakthrough therapy designation and EMA PRIME access

Dec. 21, 2016

Formation Biologics presents novel cancer candidates

Dec. 20, 2016

Adaptimmune Therapeutics and Bellicum Pharmaceuticals enter strategic agreement

Dec. 20, 2016

CHMP grants positive opinion for Truxima

Dec. 20, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...